Diagnostic Molecular Pathology

William B. Coleman, PhD is the Executive Officer for the American Society for Investigative Pathology (Rockville, MD). Prior to taking this position with the American Society for Investigative Pathology, Dr. Coleman spent 28 years at the University of North Carolina School of Medicine (Chapel Hill, NC), first as a postdoctoral fellow (1990-1995) and then as a faculty member (1995-2018) in the Department of Pathology and Laboratory Medicine. During his time at the UNC School of Medicine, Dr. Coleman served as Director of Graduate Studies for the Molecular and Cellular Pathology Ph.D. Program (2006-2012; now the Pathobiology and Translational Medicine Ph.D. Program), was a co-founder of the UNC Program in Translational Medicine and served as its Co-Director (2006-2015) and then its Director (2015-2018), was affiliated with the Curriculum in Toxicology, the Cancer Biology Training Program, and was a member of the UNC Lineberger Comprehensive Cancer Center. Dr. Coleman was active in teaching biomedical graduate students and is a four-time recipient of the Joe W. Grisham Award for Excellence in Graduate Student Teaching from the Molecular and Cellular Pathology graduate students at the UNC School of Medicine. Prior to becoming an employee, Dr. Coleman was active in the leadership of the American Society for Investigative Pathology, serving in various roles including President (2015-2016). Dr. Coleman was honored with the ASIP Outstanding Investigator Award in 2013 from the American Society for Investigative Pathology. He is also a long-time member of the American Association for Cancer Research. He serves as Senior Associate Editor for The American Journal of Pathology, and is an Associate Editor for BMC Cancer, and PLoS One, and serves on the editorial boards of Clinica Chimica Acta, Experimental and Molecular Pathology, Archives of Pathology and Laboratory Medicine, Laboratory Investigation, and Current Pathobiology Reports, and has served as an ad hoc reviewer for 99 other journals. Dr. Coleman’s major research interests are in the molecular pathogenesis of human cancers, with a specific interest in breast cancer epigenetics, liver carcinogenesis, and lung cancer biology. His research was funded by the NIH/NCI, The Susan G. Komen Breast Cancer Foundation, Friends for an Earlier Breast Cancer Test, and the UNC Lineberger Comprehensive Cancer Center. Dr. Coleman is the author of over 140 original research articles, reviews, and book chapters. In addition, Dr. Coleman has co-edited or co-authored ten books on topics related to molecular pathology, molecular diagnostics, and the molecular pathogenesis of human cancer. Gregory J. Tsongalis, PhD, HCLD, CC, FNACB., is the Vice Chair for Research and the Director of the Laboratory for Clinical Genomics and Advanced Technology (CGAT) in the Department of Pathology and Laboratory Medicine at the Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center (NCCC) in Lebanon, NH. He is a Professor of Pathology and Laboratory Medicine at the Audrey and Theodor Geisel School of Medicine at Dartmouth in Hanover, NH and a member of the NCCC Molecular Therapeutics Program and the gastrointestinal and breast cancer clinical oncology groups. In 2016 he became a member of Dartmouth College’s Program in Experimental and Molecular Medicine (PEMM), and he has served on the advisory board of the Health Care Genetics Professional Science Master’s Degree Program and Diagnostic Genetic Sciences Program at the University of Connecticut (Storrs, CT). His area of expertise is in the development and implementation of clinical molecular diagnostic technologies. His research interests are in the pathogenesis of human cancers, personalized medicine and disruptive technologies. He has authored/edited twelve textbooks in the field of molecular pathology, published more than 230 peer reviewed manuscripts, and has been an invited speaker at both national and international meetings. He has served on numerous committees of the American Association for Clinical Chemistry, the American Society for Investigative Pathology, the Federation for American Societies for Experimental Biology, and the Association for Molecular Pathology (where he is a past President). He is active in the Alliance for Clinical Trials in Oncology, the Association for Molecular Pathology, the American Association for Clinical Chemistry, the American Association of Bioanalysts, and the American Society for Investigative Pathology. He serves on the editorial boards of 8 journals including Clinical Chemistry, Experimental and Molecular Pathology, and the Journal of Molecular Diagnostics. In 2016, Dr. Tsongalis received the Norris Cotton Cancer Center Award for Excellence, in 2017 the Association for Molecular Pathology (AMP) Jeffrey A. Kant Leadership Award, and in 2019 the American Society for Investigative Pathology Robbins Distinguished Educator Award. He also serves on numerous corporate scientific advisory boards.

Section I: Introduction to Molecular Testing

Chapter 1. Basic Concepts in Molecular Pathology—Introduction to Molecular Testing in Human Disease

Chapter 2. Laboratory Approaches in Molecular Pathology—The Polymerase Chain Reaction

Chapter 3. Next-Generation Sequencing in the Clinical Laboratory

Chapter 4. Automation of the Molecular Diagnostic Laboratory

Section II: Molecular Testing in Infectious Disease

Chapter 5. Molecular Testing for Human Imunodeficiency Virus

Chapter 6. Molecular Testing in Hepatitis Virus Related Disease

Chapter 7. Molecular Testing for Human Papillomaviruses

Chapter 8. Molecular Testing for Herpes Viruses

Chapter 9. Molecular Testing for Parvoviruses

Chapter 10. Molecular Testing for Polyomaviruses

Chapter 11. Molecular Testing for Respiratory Viruses

Chapter 12. Molecular Testing for Diseases Associated with Bacterial Infections

Chapter 13. Agents Associated with Sexually Transmitted Infections

Chapter 14. Molecular Methods for Healthcare-Acquired Infections

Chapter 15. Molecular Testing in Emerging Infectious Diseases

Section III: Molecular Testing in Genetic Disease

Chapter 16. Noninvasive Prenatal Screening (NIPS) for Fetal Aneuploidies

Chapter 17. Molecular Testing in Inherited Cardiomyopathies

Chapter 18. Molecular Diagnostics for Coagulopathies

Chapter 19. Molecular Diagnosis of Cystic Fibrosis

Chapter 20. Molecular Testing in Hemochromatosis

Section IV: Molecular Testing in Oncology

Chapter 21. Molecular Testing in Breast Cancer

Chapter 22. Molecular Pathology of Prostate Cancer

Chapter 23. Molecular Testing in Lung Cancer

Chapter 24. Molecular Testing in Colorectal Cancer

Chapter 25. Molecular Pathology and Testing in Melanocytic Tumors

Chapter 26. Molecular Testing for Glioblastoma

Chapter 27. Molecular Testing in Pancreatic Cancer

Chapter 28. Molecular Testing in Gynecologic Cancer

Chapter 29. The Emerging Genetic Landscape in Renal Cell Carcinoma

Chapter 30. Molecular Testing in Thyroid Cancer

Chapter 31. Molecular Testing in Pediatric Cancers

Section V: Molecular Testing in Hematopathology

Chapter 32. Molecular Testing in Chronic Myelogenous Leukemia

Chapter 33. Molecular Testing in Acute Myeloid Leukemia

Chapter 34. Molecular Testing in Myeloproliferative Neoplasms

Chapter 35. Molecular Testing in the Assessment of Bone Marrow Transplant Engraftment

Section VI: Molecular Testing in Personalized Medicine

Chapter 36. Personalized Medicine in Cardiovascular Disease

Chapter 37. Personalized Medicine for Coagulopathies

Chapter 38. Personalized Medicine for Hepatitis C Virus

Chapter 39. Personalized Medicine in Cancer Treatment

Section VII: The Future of Molecular Testing

Chapter 40. Imaging Mass Spectrometry in Clinical Pathology

Chapter 41. Whole Genome Sequencing in the Molecular Pathology Laboratory